A vs UHS
Agilent Technologies vs Universal Health Services — AI-powered side-by-side comparison
A
Agilent Technologies
59
Buy
VS
UHS
Universal Health Services
66
Buy
| Metric | A | UHS |
|---|
| AI Score |
59
|
66
|
| Price |
$156.25
|
$175.75
|
| P/E Ratio |
30.75×
|
7.15×
|
| ROE |
19.3%
|
20.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
53.0%
|
90.7%
|
| Debt / Equity |
0.47×
|
0.70×
|
| Dividend Yield |
0.7%
|
0.5%
|
| RSI (14) |
61.3
|
67.6
|
| Beta |
1.229
|
1.063
|
| Expected Upside |
+0.2%
|
+38.3%
|
AI Committee View
Current Innellis committee reasoning for A versus UHS.
UHS leads by 7 points.
UHS scores 66/100 (Buy) versus A at 59/100 (Buy).
A Committee View
67% agreement
6 analysts
The primary driver is price structure making higher highs and higher lows. The main limiting factor is bollinger bandwidth of 17.4% signals elevated volatility. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 20.8% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 29.4 is moderate-to-rich — Value
- Price-to-book of 6.2x prices in significant intangible value — Value
- Bollinger bandwidth of 17.4% signals elevated volatility — Risk
UHS Committee View
80% agreement
5 analysts
The primary driver is eps growing 29.4% yoy. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- P/E of 6.8 is inexpensive for the broad market — Value
- ROE of 20.8% shows genuine earnings power backing the valuation — Value
- EPS growing 29.4% YoY — Growth
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.